Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

-Cheri Klein Researcher Activity Profile

Research Author Detailed Information 

profile photo of Cheri KleinCheri klein researcher

Cheri Klein Publication Rate By Year

Cheri Klein has published 1 paper(s) in 1972, 1 paper(s) in 1979, 1 paper(s) in 1986, 1 paper(s) in 2000, 1 paper(s) in 2001, 1 paper(s) in 2002, 3 paper(s) in 2005, 4 paper(s) in 2006, 72 paper(s) in 2007, 16 paper(s) in 2008, for a total of 101 research publications in total.

Cheri C Klein Author Information

LAST NAME: klein

FIRST NAME: Cheri

INITIALS: c

AFFILIATION:

Papers

Cheri Klein's Publication Record

  1. Exploratory study comparing the metabolic toxicities of a lopinavir/ritonavir plus saquinavir dual protease inhibitor regimen versus a lopinavir/ritonavir plus zidovudine/lamivudine nucleoside regimen. Year Published: 2007
  2. University of Ottawa at The Ottawa Hospital, Box 228, 501 Smyth Rd., Ottawa, ON, Canada, K1H 8L6.
  3. [Treatment of sialorrhea with botulinum toxin: an overview.] Year Published: 2005
  4. Intraovarian tumor necrosis factor-related weak inducer of apoptosis/fibroblast growth factor-inducible-14 ligand-receptor system limits ovarian preovulatory follicles from excessive luteinization. Year Published: 2006
  5. Division of Reproductive Biology, Department of Obstetrics and Gynecology, Stanford University School of Medicine, Stanford, California 94305-5317, USA.
  6. Herbicide exposure modifies GSTP1 haplotype association to Parkinson onset age: the GenePD Study. Year Published: 2006
  7. Department of Neurology, Boston University School of Medicine, 715 Albany St., E-338, Boston, MA 02118, USA. jwilk@bu.edu
  8. Assignment of the gene locus for severe congenital neutropenia to chromosome 1q22 in the original Kostmann family from Northern Sweden. Year Published: 2007
  9. Department of Genetics and Pathology, The Rudbeck Laboratory, Uppsala University, Uppsala, Sweden.
  10. Myoclonus-dystonia, obsessive-compulsive disorder, and alcohol dependence in SGCE mutation carriers. Year Published: 2007
  11. Department of Neurology, PACC, Beth Israel Medical Center, Suite 5J, 10 Union Square East, New York, NY 10003, USA.
  12. Biological effects of the PINK1 c.1366C>T mutation: implications in Parkinson disease pathogenesis. Year Published: 2007
  13. A phase 1/2 trial of arginine butyrate and ganciclovir in patients with Epstein-Barr virus-associated lymphoid malignancies. Year Published: 2007
  14. Cancer Research Center, Boston University School of Medicine, Boston, MA 02118, USA.
  15. Large granular lymphocyte proliferation and revertant mosaicism: two rare events in a Wiskott-Aldrich syndrome patient. Year Published: 2007
  16. Department of Pediatric Hematology/Oncology, Medical School Hannover, D-30625 Hannover, Germany.
  17. Lymphocyte-dependent and Th2 cytokine-associated colitis in mice deficient in Wiskott-Aldrich syndrome protein. Year Published: 2007
  18. Gastrointestinal Unit, Massachusetts General Hospital, Boston, Massachusetts 02114, USA.
  19. Construction and validation of a Parkinson's disease mutation genotyping array for the Parkin gene. Year Published: 2007
  20. Department of Pathology, Columbia University, New York, New York 10032, USA. LC654@columbia.edu
  21. Impact of recent genetic findings in Parkinson's disease. Year Published: 2007
  22. Engineering of efficient phosphorescent iridium cationic complex for developing oxygen-sensitive polymeric and nanostructured films. Year Published: 2007
  23. Department of Analytical Chemistry, Faculty of Sciences, University of Granada, C/Fuentenueva, s/n E-18071 Granada, Spain.
  24. A one-session human immunodeficiency virus risk-reduction intervention in adolescents with psychiatric and substance use disorders. Year Published: 2007
  25. Denver Health and Hospital Authority, and the University of Colorado Health Sciences Center at Denver, CO 80204, USA. Christian.Thurstone@dhha.org
  26. Further evidence for a somatic KRAS mutation in a pilocytic astrocytoma. Year Published: 2007
  27. Department of Neurology, University Hospital Freiburg, Freiburg, Germany.
  28. Post transplant lymphoproliferative disease in pediatric solid organ transplant patients: a possible role for [18F]-FDG-PET(/CT) in initial staging and therapy monitoring. Year Published: 2007
  29. Department of Diagnostic Radiology, Medizinische Hochschule Hannover (Medical School Hanover), Carl-Neuberg-Strasse 1, 30625 Hannover, Germany. Falck.Christian.von@mh-hannover.de
  30. Apolipoprotein A-II is catabolized in the kidney as a function of its plasma concentration. Year Published: 2007
  31. Rapid and reliable detection of exon rearrangements in various movement disorders genes by multiplex ligation-dependent probe amplification. Year Published: 2007
  32. Severe congenital neutropenia: new genes explain an old disease. Year Published: 2007
  33. Department of Pediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany.
  34. Healthcare systems engineering: an interdisciplinary approach to achieving continuous improvement. Year Published: 2007
  35. Lymphocyte-dependent and Th2 cytokine-associated colitis in mice deficient in Wiskott-Aldrich syndrome protein. Year Published: 2007
  36. Gastrointestinal Unit, Massachusetts General Hospital, Boston, Massachusetts 02114, USA.
  37. Role of ethnicity on the association of MAPT H1 haplotypes and subhaplotypes in Parkinson's disease. Year Published: 2007
  38. Substantia nigra hyperechogenicity correlates with clinical status and number of Parkin mutated alleles. Year Published: 2007
  39. alpha-Synuclein and Parkinson disease susceptibility. Year Published: 2007
  40. CNS or bone marrow involvement as risk factors for poor survival in post-transplantation lymphoproliferative disorders in children after solid organ transplantation. Year Published: 2007
  41. Department of Pediatric Hematology/Oncology, Hannover Medical School, Hannover, Germany. maecker.britta@mh-hannover.de
  42. Mechanism of nuclear calcium signaling by inositol 1,4,5-trisphosphate produced in the nucleus, nuclear located protein kinase C and cyclic AMP-dependent protein kinase. Year Published: 2007
  43. INSERM U575, University Louis Pasteur, 11 rue Humann, 67000 Strasbourg, France.
  44. Autosomal dominant myoclonus-dystonia and Tourette syndrome in a family without linkage to the SGCE gene. Year Published: 2007
  45. Department of Neurology, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.
  46. A randomized controlled trial of fluoxetine and cognitive behavioral therapy in adolescents with major depression, behavior problems, and substance use disorders. Year Published: 2007
  47. Department of Psychiatry, University of Colorado at Denver and Health Sciences Center, Denver, CO 80262, USA. paula.riggs@uchsc.edu
  48. MECP2 mutations in Serbian Rett syndrome patients. Year Published: 2007
  49. Faculty of Biology, University of Belgrade, Belgrade, Serbia. ana.djarmati@neuro.uni-luebeck.de
  50. Efficiency Enhancements in Solid-State Hybrid Solar Cells via Reduced Charge Recombination and Increased Light Capture. Year Published: 2007
  51. Aspergillus fumigatus und Angiogenese. Von einer Zufallsentdeckung zum Rationalen Drug-Design. Year Published: 2007
  52. Sensorimotor integration is abnormal in asymptomatic Parkin mutation carriers: a TMS study. Year Published: 2007
  53. Department of Neurology, University of Hamburg, Martinistrasse 52, 20246 Hamburg, Germany. baeumer@uke.de
  54. Parkinson disease, 10 years after its genetic revolution: multiple clues to a complex disorder. Year Published: 2007
  55. NKCC2 surface expression in mammalian cells: down-regulation by novel interaction with aldolase B. Year Published: 2007
  56. INSERM U652, 75006 Paris, France.
  57. Role of ethnicity on the association of MAPT H1 haplotypes and subhaplotypes in Parkinson's disease. Year Published: 2007
  58. Healthcare systems engineering: an interdisciplinary approach to achieving continuous improvement. Year Published: 2007
  59. Department of Industrial and Manufacturing Systems Engineering, University of Missouri-Columbia, Columbia, MO 65211, USA. WuBi@missouri.edu
  60. Mechanism of nuclear calcium signaling by inositol 1,4,5-trisphosphate produced in the nucleus, nuclear located protein kinase C and cyclic AMP-dependent protein kinase. Year Published: 2007
  61. INSERM U575, University Louis Pasteur, 11 rue Humann, 67000 Strasbourg, France.
  62. A randomized controlled trial of fluoxetine and cognitive behavioral therapy in adolescents with major depression, behavior problems, and substance use disorders. Year Published: 2007
  63. Department of Psychiatry, University of Colorado at Denver and Health Sciences Center, Denver, CO 80262, USA. paula.riggs@uchsc.edu
  64. Efficiency enhancements in solid-state hybrid solar cells via reduced charge recombination and increased light capture. Year Published: 2007
  65. Stable, high-efficiency ionic-liquid-based mesoscopic dye-sensitized solar cells. Year Published: 2007
  66. Sensorimotor integration is abnormal in asymptomatic Parkin mutation carriers: a TMS study. Year Published: 2007
  67. Department of Neurology, University of Hamburg, Martinistrasse 52, 20246 Hamburg, Germany. baeumer@uke.de
  68. Biological effects of the PINK1 c.1366C>T mutation: implications in Parkinson disease pathogenesis. Year Published: 2007
  69. [In process citation] Year Published: 2007
  70. Apolipoprotein A-II is catabolized in the kidney as a function of its plasma concentration. Year Published: 2007
  71. Parkinson disease, 10 years after its genetic revolution: multiple clues to a complex disorder. Year Published: 2007
  72. Distal lesion of the lateral femoral cutaneous nerve. Year Published: 2007
  73. Department of Neurology, Assaf Harofeh Medical Center, Zerifin 70300, Israel.
  74. Impact of recent genetic findings in Parkinson's disease. Year Published: 2007
  75. Engineering of efficient phosphorescent iridium cationic complex for developing oxygen-sensitive polymeric and nanostructured films. Year Published: 2007
  76. Department of Analytical Chemistry, Faculty of Sciences, University of Granada, C/Fuentenueva, s/n E-18071 Granada, Spain.
  77. Autologous repair of an internal carotid artery aneurysm by resection, caliber reduction, and external mesh tube reinforcement in a 9-year-old boy. Year Published: 2007
  78. Department of Thoracic and Cardiovascular Surgery, Johann Wolfgang Goethe University Hospital, Frankfurt, Germany.
  79. Delayed-onset dystonia due to perinatal asphyxia: A prospective study. Year Published: 2007
  80. Institute of Neurology and Psychiatry for Children and Youth, Belgrade, Serbia.
  81. Functional MRI reveals activation of a subcortical network in a 5-year-old girl with genetically confirmed myoclonus-dystonia. Year Published: 2006
  82. Further evidence for a somatic KRAS mutation in a pilocytic astrocytoma. Year Published: 2007
  83. Department of Neurology, University Hospital Freiburg, Freiburg, Germany.
  84. Exploratory study comparing the metabolic toxicities of a lopinavir/ritonavir plus saquinavir dual protease inhibitor regimen versus a lopinavir/ritonavir plus zidovudine/lamivudine nucleoside regimen. Year Published: 2007
  85. University of Ottawa at The Ottawa Hospital, Box 228, 501 Smyth Rd., Ottawa, ON, Canada, K1H 8L6.
  86. NKCC2 surface expression in mammalian cells: down-regulation by novel interaction with aldolase B. Year Published: 2007
  87. INSERM U652, 75006 Paris, France.
  88. Role of ethnicity on the association of MAPT H1 haplotypes and subhaplotypes in Parkinson's disease. Year Published: 2007
  89. Post transplant lymphoproliferative disease in pediatric solid organ transplant patients: a possible role for [18F]-FDG-PET(/CT) in initial staging and therapy monitoring. Year Published: 2007
  90. Department of Diagnostic Radiology, Medizinische Hochschule Hannover (Medical School Hanover), Carl-Neuberg-Strasse 1, 30625 Hannover, Germany. Falck.Christian.von@mh-hannover.de
  91. [On chance discovery in rational drug design. Aspergillus fumigatus and angiogenesis] Year Published: 2007
  92. Rapid and reliable detection of exon rearrangements in various movement disorders genes by multiplex ligation-dependent probe amplification. Year Published: 2007
  93. Efficiency enhancements in solid-state hybrid solar cells via reduced charge recombination and increased light capture. Year Published: 2007
  94. Substantia nigra hyperechogenicity correlates with clinical status and number of Parkin mutated alleles. Year Published: 2007
  95. MECP2 mutations in Serbian Rett syndrome patients. Year Published: 2007
  96. Faculty of Biology, University of Belgrade, Belgrade, Serbia. ana.djarmati@neuro.uni-luebeck.de
  97. Stable, high-efficiency ionic-liquid-based mesoscopic dye-sensitized solar cells. Year Published: 2007
  98. [In Process Citation] Year Published: 2007
  99. Urologische Klinik, Klinikum, Stenglinstrasse 2, 86156 Augsburg. dorothea.weckermann@uro.augsburg-med.de
  100. [In Process Citation] Year Published: 2007
  101. Urologische Klinik, Klinikum, Stenglinstrasse 2, 86156 Augsburg. dorothea.weckermann@uro.augsburg-med.de
  102. Functional MRI reveals activation of a subcortical network in a 5-year-old girl with genetically confirmed myoclonus-dystonia. Year Published: 2006
  103. Further evidence for a somatic KRAS mutation in a pilocytic astrocytoma. Year Published: 2007
  104. Department of Neurology, University Hospital Freiburg, Freiburg, Germany.
  105. A high molar extinction coefficient sensitizer for stable dye-sensitized solar cells. Year Published: 2005
  106. Laboratory for Photonics & Interfaces, Swiss Federal Institute of Technology, CH 1015, Lausanne, Switzerland.
  107. Sensitive biochemical aggregate detection reveals aggregation onset before symptom development in cellular and murine models of Huntington's disease. Year Published: 2008
  108. Neuroscience Discovery, Novartis Institutes for BioMedical Research, Basel, Switzerland.
  109. Genetic heterogeneity in severe congenital neutropenia: how many aberrant pathways can kill a neutrophil? Year Published: 2007
  110. Computational Biology Branch, National Center for Biotechnology Information, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland, USA.
  111. Distal lesion of the lateral femoral cutaneous nerve. Year Published: 2007
  112. Department of Neurology, Assaf Harofeh Medical Center, Zerifin 70300, Israel. mrabey@asaf.health
  113. Establishment of immortalized multipotent hematopoietic progenitor cell lines by retroviral-mediated gene transfer of beta-catenin. Year Published: 2008
  114. Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany.
  115. Biological effects of the PINK1 c.1366C>T mutation: implications in Parkinson disease pathogenesis. Year Published: 2007
  116. Myoclonus-dystonia: significance of large SGCE deletions. Year Published: 2008
  117. Autologous repair of an internal carotid artery aneurysm by resection, caliber reduction, and external mesh tube reinforcement in a 9-year-old boy. Year Published: 2007
  118. Department of Thoracic and Cardiovascular Surgery, Johann Wolfgang Goethe University Hospital, Frankfurt, Germany. nestoras.papadopoulos@gmail.com
  119. Severe congenital neutropenia: new genes explain an old disease. Year Published: 2007
  120. Department of Pediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany.
  121. Autosomal dominant myoclonus-dystonia and Tourette syndrome in a family without linkage to the SGCE gene. Year Published: 2007
  122. Department of Neurology, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.
  123. Healthcare systems engineering: an interdisciplinary approach to achieving continuous improvement. Year Published: 2007
  124. Department of Industrial and Manufacturing Systems Engineering, University of Missouri-Columbia, Columbia, MO 65211, USA. WuBi@missouri.edu
  125. Delayed-onset dystonia due to perinatal asphyxia: a prospective study. Year Published: 2007
  126. Institute of Neurology and Psychiatry for Children and Youth, Belgrade, Serbia.
  127. Autologous repair of an internal carotid artery aneurysm by resection, caliber reduction, and external mesh tube reinforcement in a 9-year-old boy. Year Published: 2007
  128. Department of Thoracic and Cardiovascular Surgery, Johann Wolfgang Goethe University Hospital, Frankfurt, Germany. nestoras.papadopoulos@gmail.com
  129. Myoclonus-dystonia: significance of large SGCE deletions. Year Published: 2008
  130. Department of Neurology, Lübeck University, Lübeck, Germany.
  131. [Living donor liver transplantation.] Year Published: 2008
  132. Klinik für Allgemein- und Transplantationschirurgie, Universitätsklinikum, Essen, Deutschland, broelsch@t-online.de.
  133. [The biosynthesis of fatty acids in dependence of age (author's transl)] Year Published: 1979
  134. [Biologic aging. 24. Circadian rhythm of lipid metabolism parameters in relation to age] Year Published: 1986
  135. Optomotor and neuropsychological performance in old age. Year Published: 2000
  136. Department of Psychology, University of Freiburg, Germany. klein@psychologie.uni-freiburg.de
  137. Developmental functions for saccadic eye movement parameters derived from pro- and antisaccade tasks. Year Published: 2001
  138. Department of Psychology, University of Freiburg, Germany. klein@psychologie.uni-freiburg.de
  139. Effects of methylphenidate on saccadic responses in patients with ADHD. Year Published: 2002
  140. Psychophysiology Research Group, Department of Psychology, University of Freiburg, Belfortstrasse 20, 79085 Freiburg, Germany. klein@psychologie.uni-freiburg.de
  141. Developmental fractionation and differential discrimination of the anti-saccadic direction error. Year Published: 2005
  142. School of Psychology, University of Wales, The Brigantia Building, Penrallt Road, Bangor, Gwynedd, Wales LL57 2AS, UK. c.klein@bangor.ac.uk
  143. DYT16: a new twist to familial dystonia. Year Published: 2008
  144. Department of Neurology, University of Lübeck; Ratzeburger Allee 160, 23538 Lübeck, Germany.
  145. Sensitive biochemical aggregate detection reveals aggregation onset before symptom development in cellular and murine models of Huntington's disease. Year Published: 2008
  146. Neuroscience Discovery, Novartis Institutes for BioMedical Research, Basel, Switzerland.
  147. [Immunofluorescent demonstration of glucagon secreting islet cells in the bony fish Xiphophorus helleri H] Year Published: 1972
  148. Delayed-onset dystonia due to perinatal asphyxia: a prospective study. Year Published: 2007
  149. Institute of Neurology and Psychiatry for Children and Youth, Belgrade, Serbia.
  150. Establishment of immortalized multipotent hematopoietic progenitor cell lines by retroviral-mediated gene transfer of beta-catenin. Year Published: 2008
  151. Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany. templin.christian@mh-hannover.de
  152. Intrathecal rituximab treatment for pediatric post-transplant lymphoproliferative disorder of the central nervous system. Year Published: 2008
  153. Department of Pediatric Hematology and Oncology, University Medical Centre St Radboud, Nijmegen, The Netherlands.
  154. [First experiences in maxillary arch expansion using the MWD (Maxillary Widening Device)] Year Published: 2007
  155. An institutional study on thymomas and thymic carcinomas: experience in 77 patients. Year Published: 2008
  156. Department of Pathology, University of Heidelberg, Heidelberg, Germany.
  157. Synthesis, characterization, and DFT/TD-DFT calculations of highly phosphorescent blue light-emitting anionic iridium complexes. Year Published: 2008
  158. Laboratory for Photonics and Interfaces, Station 6, Institute of Chemical Sciences and Engineering, School of basic Sciences, Swiss Federal Institute of Technology, CH-1015 Lausanne, Switzerland.
  159. Bilateral subthalamic stimulation in Parkin and PINK1 parkinsonism. Year Published: 2008
  160. Movement Disorder Centre, Toronto Western Hospital, University of Toronto, Ontario, Canada.
  161. The DRD2 TaqIA polymorphism and demand of dopaminergic medication in Parkinson's disease. Year Published: 2008
  162. Department of Neurology, University of Bonn, Bonn, Germany.
  163. Phenotypic spectrum and sex effects in eleven myoclonus-dystonia families with epsilon-sarcoglycan mutations. Year Published: 2008
  164. The Alan and Barbara Mirken Department of Neurology, Beth Israel Medical Center, New York, New York.
  165. The DRD2 TaqIA polymorphism and demand of dopaminergic medication in Parkinson's disease. Year Published: 2008
  166. Department of Neurology, University of Bonn, Bonn, Germany. spaus@uni-bonn.de
  167. Phenotypic spectrum and sex effects in eleven myoclonus-dystonia families with epsilon-sarcoglycan mutations. Year Published: 2008
  168. The Alan and Barbara Mirken Department of Neurology, Beth Israel Medical Center, New York, New York 10003, USA.
 

Molecular Station USER Menu

Welcome to Molecular Station!

You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

Already registered? Login now below.

User Name:

Password:

Already registered and Forgot your password? Click below to recover it.

Recover Lost Password

Join now - it's fast and free!

Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

Research Terms of Usage and Disclaimer
Home
Features

Protocols

DNA Forum

Science Forum

DNA Forum
Biology Forum

Science News


[CaRP] XML error: Invalid document end at line 2

For more click here:Science News